KA

Kabeer Aziz

Co-founder & Partner // Adjuvant Capital

New York, New York

Investor
VC
Founder

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Investments

Minervax

Series B

Total Funding: $140M

LimmaTech Biologics

Series A

Total Funding: $36M

Pulmocide

Series C

Total Funding: $140M

Work Experience

Adjuvant Capital

2018

  • Partner

    2018

    Leading life sciences investment fund focused on global public health Board of Directors: AN2 Therapeutics, MinervaX, Pulmocide, Quantoom Biosciences, Frontier Nutrition Board Observer: YS Biopharma (2020-2022), Themis (2018-2020)

Global Health Investment Fund

2015 - 2018

  • Senior Associate

    2015 - 2018

    Impact investing to finance global health research & development

Metalmark Capital

2013 - 2015

  • Associate

    2013 - 2015

    Private / Growth Equity (Healthcare)

Greenhill & Co.

2010 - 2013

  • Analyst

    2010 - 2013

    Mergers & Acquisitions (Pharma and MedTech)